Human medicines European public assessment report (EPAR): Nplate, romiplostim, Purpura, Thrombocytopenic, Idiopathic, Date of authorisation: 04/02/2009, Revision: 26, Status: Authorised | Human medicines European public assessment report (EPAR): Nplate, romiplostim, Purpura, Thrombocytopenic, Idiopathic, Date of authorisation: 04/02/2009, Revision: 26, Status: Authorised | | Human medicines European public assessment report (EPAR): Ilumetri, tildrakizumab, Psoriasis, Date of authorisation: 17/09/2018, Revision: 7, Status: Authorised | Human medicines European public assessment report (EPAR): Ilumetri, tildrakizumab, Psoriasis, Date of authorisation: 17/09/2018, Revision: 7, Status: Authorised | | Human medicines European public assessment report (EPAR): Repatha, evolocumab, Dyslipidemias;Hypercholesterolemia, Date of authorisation: 17/07/2015, Revision: 22, Status: Authorised | Human medicines European public assessment report (EPAR): Repatha, evolocumab, Dyslipidemias;Hypercholesterolemia, Date of authorisation: 17/07/2015, Revision: 22, Status: Authorised | | |